Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sight Diagnostics

Request full access

Sight Diagnostics is a medical device company bringing affordable, accurate diagnostics to the point-of-care

Bnei Brak, IsraelFounded 2011Biotech & Life Sciences

About Sight Diagnostics

Sight Diagnostics, the company behind Sight OLO, operates in the healthcare technology market, providing innovative solutions for blood testing. The company's flagship product, Sight OLO, is a high-performance complete blood count (CBC) analyzer that delivers accurate results within minutes. This product is FDA 510(k) cleared for use in moderately complex laboratories, making it a reliable tool for healthcare providers.

Sight OLO's primary clients are healthcare practices that require quick and accurate blood test results. The device is easy to use and doesn't require calibration or maintenance, making it a practical choice for busy healthcare environments. It uses a small blood sample, either from a finger prick or venous draw, and processes the results in minutes. This quick turnaround time allows healthcare providers to make immediate treatment decisions, reducing patient anxiety and potentially improving health outcomes.

The business model of Sight Diagnostics is based on the sale of the Sight OLO device to healthcare providers. The company generates revenue from the sale of these devices, which are designed to streamline the workflow of healthcare practices and improve patient care.

Sight Diagnostics has been recognized for its innovative approach, being named one of the 2021 CNBC Disruptor 50 Companies, a 2021 Bronze Winner, and receiving an honorable mention in the 2021 World Changing Ideas Awards. It was also a quarterfinalist in the 2020 UCSF Digital Health Awards.

Source: Dealroom company data

At a glance

Status
Operational
Employees
66
Open positions
None listed
Dealroom signal
64.4/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Testing, Data Analytics, Biotechnology, Medical Imaging, Core AI, Health Diagnostics, Tech for Hospitals and Clinics, Clinical Decision Support, Hard Tech, AI Applications
Business model
Manufacturing

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Jul 2020 $12M $47M OurCrowd —
SERIES DOther financing Jul 2020 $71M $284M Clal Biotechnology Industries —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Sight Diagnostics website traffic

Latest recorded traffic for Sight Diagnostics is 1.1K monthly website visits, up 100% over the last three months. Sight Diagnostics's team declined 1.5% over the past year.

Latest monthly visits1.1K 3-month web change+100% 1-year team growth-1.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Sight Diagnostics in the Bnei Brak ecosystem

Live from Dealroom

The Sight Diagnostics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A5 investors entered at this stage

  • Innovation Endeavors
  • Clal Biotechnology Industries
  • Emery Capital
  • GEOC - China-Israel fund
  • New Alliance Capital

Series B and later4 investors entered at this stage

  • Longliv Ventures
  • GO Capital
  • Steve Erick
  • Jack Nicklaus II
Team profiled 21 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Sight Diagnostics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.